SHANGHAI BIOMABS PHARMACEUTICALS CO LTD has a total of 19 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are ALLIGATOR BIOSCIENCE AB, ADHERON THERAPEUTICS INC and SYNOVEX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 4 | |
#4 | Brazil | 3 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Qian Weizhu | 8 |
#2 | Li Chuan | 6 |
#3 | Tong Xin | 6 |
#4 | Guo Huaizu | 4 |
#5 | Kan Ying | 4 |
#6 | Xin Tong | 3 |
#7 | Chuan Li | 3 |
#8 | Xu Jin | 3 |
#9 | Ying Kan | 2 |
#10 | Kou Geng | 2 |
Publication | Filing date | Title |
---|---|---|
CN111349674A | Method for improving expression level of recombinant protein in CHO (Chinese hamster ovary) cell | |
CN111349142A | Protein purification method | |
CN107686521A | A kind of humanized anti-IgE monoclonal's antibody | |
CN107619442A | One kind recombinates the anti-full human monoclonal antibody preparations of TNF α | |
EP2540743A1 | Fully human anti-tnf-alpha monoclonal antibody, preparation method and use thereof | |
BR112012021327A2 | humanized anti-her2 monoclonal antibody, method of preparation and use thereof. | |
CA2790014A1 | Fully human anti-vegf monoclonal antibody, preparation method and use thereof |